MacroGenics (MGNX) Stock: Buy, Sell, or Hold?
MGNX - MacroGenics, Inc.
$4.00
0.03 (0.76%)
▲
5d:
-5.88%
30d:
-0.5%
90d:
-0.25%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MGNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MGNX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MGNX is currently trading at $4.00, which is considered slightly low relative to its 30-day fair value range of $3.98 to $4.22.
Technical Outlook: Technically, MGNX is in a uptrend. The price is currently testing key support at $3.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+100.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MGNX is in a uptrend. The price is currently testing key support at $3.89. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $8.00 (+100.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.98 -
$4.22
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.0% below Wall St target ($8.00)
- NEUTRAL: Bottoming setup forming (47/100) — watch for confirmation
- CAUTION: 5-day price weakness (-5.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$3.98 -
$4.22
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.51
(12.7%)
Support & Resistance Levels
Support Level
$3.89
Resistance Level
$4.49
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.73
Wall Street Target
$8.00
(+100.0%)
Revenue Growth (YoY)
378.0%
Earnings Growth (YoY)
-70.4%
Profit Margin
-8.3%
Share & Embed Analysis
Last updated: September 13, 2026 2:48 PM ET
Data refreshes hourly during market hours. Next update: 3:48 PM
Data refreshes hourly during market hours. Next update: 3:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MGNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$849 | 50 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
